1. Home
  2. OLED vs HALO Comparison

OLED vs HALO Comparison

Compare OLED & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OLED

Universal Display Corporation

HOLD

Current Price

$121.78

Market Cap

5.7B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$69.98

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLED
HALO
Founded
1985
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
7.4B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
OLED
HALO
Price
$121.78
$69.98
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$181.33
$73.33
AVG Volume (30 Days)
506.7K
2.1M
Earning Date
02-19-2026
02-17-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
56.68
EPS
4.64
4.74
Revenue
$639,977,000.00
$1,242,852,000.00
Revenue This Year
$2.50
$34.83
Revenue Next Year
$10.90
$24.84
P/E Ratio
$26.26
$14.85
Revenue Growth
N/A
31.19
52 Week Low
$103.70
$47.50
52 Week High
$164.29
$79.50

Technical Indicators

Market Signals
Indicator
OLED
HALO
Relative Strength Index (RSI) 53.95 60.54
Support Level $116.69 $67.02
Resistance Level $120.32 $69.48
Average True Range (ATR) 2.53 1.65
MACD 0.70 0.52
Stochastic Oscillator 84.52 97.15

Price Performance

Historical Comparison
OLED
HALO

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: